{
  "id": 369374,
  "title": "Breast Implants. BIA-ALCL. Avoiding Misinterpretations.",
  "url": "/competitions/rsna-breast-cancer-detection/discussion/369374",
  "author_name": "Marília Prata",
  "post_date": "2022-11-30T01:45:19.053000",
  "votes": 8,
  "comment_count": 0,
  "views": 0,
  "content": "<h1>Normal Breast Implants. What We Must Know to Avoid Misinterpretations</h1>\n<p>\"Nowadays there are many different types of breast implants and some of them with particular landmarks that could lead to misinterpretations by unexperienced radiologists.The authors selected 10 types of implants from different manufacturers commonly used in plastic surgery.The purpose of this exhibit is: To demonstrate the most common types of breast implants, especially some specific landmarks and main anatomical features that could lead to misinterpretations; To demonstrate in detail the microscopic anatomical characteristics of breast implants shell; To correlate the findings of both in vitro and in vivo through different imaging modalities: mammography, ultrasound and MRI.\"</p>\n<p><a href=\"https://archive.rsna.org/2015/MagneticResonanceImaging.pdf\" target=\"_blank\">https://archive.rsna.org/2015/MagneticResonanceImaging.pdf</a></p>\n<h1>What is breast implant associated cancer?</h1>\n<p>\"Breast implant associated cancer, which is also known as breast implant associated anaplastic large cell lymphoma (BIA-ALCL), is a rare cancer of the immune system. It is not breast cancer, which forms from cells in the breast, but instead a cancer that grows in the fluid and scar tissue that forms around a breast implant. Less commonly, BIA-ALCL can take the form of a lump in the breast or a lump in the armpit.\"</p>\n<p>\"BIA-ALCL has been known to occur as soon as one year after the operation and as late as 37 years after the operation. The average time to diagnosis is within 8 years of the operation.\"</p>\n<p><a href=\"https://www.tga.gov.au/breast-implant-associated-cancer-bia-alcl-information-consumers\" target=\"_blank\">https://www.tga.gov.au/breast-implant-associated-cancer-bia-alcl-information-consumers</a></p>\n<h1>What is BIA-ALCL? Is BIA-ALCL breast cancer?</h1>\n<p>Breast Implant Associated Lymphoma (BIA-ALCL) is not breast cancer - it is a type of non-Hodgkin's lymphoma (cancer of the immune system). In most cases, BIA-ALCL is found in the scar tissue and fluid near the implant, but in some cases, it can spread throughout the body. An individual's risk of developing BIA-ALCL is considered to be low; however, this cancer is serious and can lead to death, especially if not treated promptly. In most patients, it is treated successfully with surgery to remove the implant and surrounding scar tissue, and in some patients, also treatment with chemotherapy and radiation therapy.</p>\n<p><a href=\"https://www.fda.gov/medical-devices/breast-implants/questions-and-answers-about-breast-implant-associated-anaplastic-large-cell-lymphoma-bia-alcl#:~:text=A2.,can%20spread%20throughout%20the%20body\" target=\"_blank\">https://www.fda.gov/medical-devices/breast-implants/questions-and-answers-about-breast-implant-associated-anaplastic-large-cell-lymphoma-bia-alcl#:~:text=A2.,can%20spread%20throughout%20the%20body</a>.</p>\n<h1>Who can get breast implant associated cancer?</h1>\n<p>\"All reported cases of breast implant associated cancer in Australia involve patients who have had a textured implant at some point in their life. Based on current evidence, experts do not think breast implant associated cancer is related to either the contents (saline/silicone) or shape (round/teardrop) of the implant.\"</p>\n<p>\"Breast implant associated cancer is rare. The recent review by the TGA has found between one in 2,500 and one in 25,000 people with breast implants are diagnosed with the condition in Australia; based on confirmed cases of BIA-ALCL where only one brand of implant had been used. The risk of developing BIA-ALCL increases with increasing texturing of the implant. Implants which have a smooth surfaced have not been associated with BIA-ALCL. Breast implant associated cancer can occur after either reconstruction or augmentation surgery, with 95% of cases occurring between three and 14 years after the insertion of an implant.'</p>\n<p><a href=\"https://www.tga.gov.au/breast-implant-associated-cancer-bia-alcl-information-consumers\" target=\"_blank\">https://www.tga.gov.au/breast-implant-associated-cancer-bia-alcl-information-consumers</a></p>\n<h1>How is breast implant associated cancer diagnosed?</h1>\n<p>\"If you develop swelling of an implanted breast your doctor will send you for an ultrasound scan to see if this is due to a fluid collection. If fluid is present it will be removed and sent to the laboratory for analysis. Most fluid collections are not due to BIA-ALCL, but the laboratory test will be able to tell for sure.\"</p>\n<p>\"If confirmed, your specialist may also order an MRI scan or CT scan to assess the extent of local growth or distant spread of the cancer. Other tests such as a PET scan may be also used to assess spread.\"</p>\n<p>\"A mammogram will check for breast cancer, but is not useful for detecting BIA-ALCL.\"</p>\n<p><a href=\"https://www.tga.gov.au/breast-implant-associated-cancer-bia-alcl-information-consumers\" target=\"_blank\">https://www.tga.gov.au/breast-implant-associated-cancer-bia-alcl-information-consumers</a></p>",
  "messages": [
    {
      "id": 2049200,
      "postDate": "2022-11-30T01:45:19.053Z",
      "content": "<h1>Normal Breast Implants. What We Must Know to Avoid Misinterpretations</h1>\n<p>\"Nowadays there are many different types of breast implants and some of them with particular landmarks that could lead to misinterpretations by unexperienced radiologists.The authors selected 10 types of implants from different manufacturers commonly used in plastic surgery.The purpose of this exhibit is: To demonstrate the most common types of breast implants, especially some specific landmarks and main anatomical features that could lead to misinterpretations; To demonstrate in detail the microscopic anatomical characteristics of breast implants shell; To correlate the findings of both in vitro and in vivo through different imaging modalities: mammography, ultrasound and MRI.\"</p>\n<p><a href=\"https://archive.rsna.org/2015/MagneticResonanceImaging.pdf\" target=\"_blank\">https://archive.rsna.org/2015/MagneticResonanceImaging.pdf</a></p>\n<h1>What is breast implant associated cancer?</h1>\n<p>\"Breast implant associated cancer, which is also known as breast implant associated anaplastic large cell lymphoma (BIA-ALCL), is a rare cancer of the immune system. It is not breast cancer, which forms from cells in the breast, but instead a cancer that grows in the fluid and scar tissue that forms around a breast implant. Less commonly, BIA-ALCL can take the form of a lump in the breast or a lump in the armpit.\"</p>\n<p>\"BIA-ALCL has been known to occur as soon as one year after the operation and as late as 37 years after the operation. The average time to diagnosis is within 8 years of the operation.\"</p>\n<p><a href=\"https://www.tga.gov.au/breast-implant-associated-cancer-bia-alcl-information-consumers\" target=\"_blank\">https://www.tga.gov.au/breast-implant-associated-cancer-bia-alcl-information-consumers</a></p>\n<h1>What is BIA-ALCL? Is BIA-ALCL breast cancer?</h1>\n<p>Breast Implant Associated Lymphoma (BIA-ALCL) is not breast cancer - it is a type of non-Hodgkin's lymphoma (cancer of the immune system). In most cases, BIA-ALCL is found in the scar tissue and fluid near the implant, but in some cases, it can spread throughout the body. An individual's risk of developing BIA-ALCL is considered to be low; however, this cancer is serious and can lead to death, especially if not treated promptly. In most patients, it is treated successfully with surgery to remove the implant and surrounding scar tissue, and in some patients, also treatment with chemotherapy and radiation therapy.</p>\n<p><a href=\"https://www.fda.gov/medical-devices/breast-implants/questions-and-answers-about-breast-implant-associated-anaplastic-large-cell-lymphoma-bia-alcl#:~:text=A2.,can%20spread%20throughout%20the%20body\" target=\"_blank\">https://www.fda.gov/medical-devices/breast-implants/questions-and-answers-about-breast-implant-associated-anaplastic-large-cell-lymphoma-bia-alcl#:~:text=A2.,can%20spread%20throughout%20the%20body</a>.</p>\n<h1>Who can get breast implant associated cancer?</h1>\n<p>\"All reported cases of breast implant associated cancer in Australia involve patients who have had a textured implant at some point in their life. Based on current evidence, experts do not think breast implant associated cancer is related to either the contents (saline/silicone) or shape (round/teardrop) of the implant.\"</p>\n<p>\"Breast implant associated cancer is rare. The recent review by the TGA has found between one in 2,500 and one in 25,000 people with breast implants are diagnosed with the condition in Australia; based on confirmed cases of BIA-ALCL where only one brand of implant had been used. The risk of developing BIA-ALCL increases with increasing texturing of the implant. Implants which have a smooth surfaced have not been associated with BIA-ALCL. Breast implant associated cancer can occur after either reconstruction or augmentation surgery, with 95% of cases occurring between three and 14 years after the insertion of an implant.'</p>\n<p><a href=\"https://www.tga.gov.au/breast-implant-associated-cancer-bia-alcl-information-consumers\" target=\"_blank\">https://www.tga.gov.au/breast-implant-associated-cancer-bia-alcl-information-consumers</a></p>\n<h1>How is breast implant associated cancer diagnosed?</h1>\n<p>\"If you develop swelling of an implanted breast your doctor will send you for an ultrasound scan to see if this is due to a fluid collection. If fluid is present it will be removed and sent to the laboratory for analysis. Most fluid collections are not due to BIA-ALCL, but the laboratory test will be able to tell for sure.\"</p>\n<p>\"If confirmed, your specialist may also order an MRI scan or CT scan to assess the extent of local growth or distant spread of the cancer. Other tests such as a PET scan may be also used to assess spread.\"</p>\n<p>\"A mammogram will check for breast cancer, but is not useful for detecting BIA-ALCL.\"</p>\n<p><a href=\"https://www.tga.gov.au/breast-implant-associated-cancer-bia-alcl-information-consumers\" target=\"_blank\">https://www.tga.gov.au/breast-implant-associated-cancer-bia-alcl-information-consumers</a></p>",
      "rawMarkdown": "#Normal Breast Implants. What We Must Know to Avoid Misinterpretations\n\n\n\"Nowadays there are many different types of breast implants and some of them with particular landmarks that could lead to misinterpretations by unexperienced radiologists.The authors selected 10 types of implants from different manufacturers commonly used in plastic surgery.The purpose of this exhibit is: To demonstrate the most common types of breast implants, especially some specific landmarks and main anatomical features that could lead to misinterpretations; To demonstrate in detail the microscopic anatomical characteristics of breast implants shell; To correlate the findings of both in vitro and in vivo through different imaging modalities: mammography, ultrasound and MRI.\"\n\nhttps://archive.rsna.org/2015/MagneticResonanceImaging.pdf\n\n#What is breast implant associated cancer?\n\n\"Breast implant associated cancer, which is also known as breast implant associated anaplastic large cell lymphoma (BIA-ALCL), is a rare cancer of the immune system. It is not breast cancer, which forms from cells in the breast, but instead a cancer that grows in the fluid and scar tissue that forms around a breast implant. Less commonly, BIA-ALCL can take the form of a lump in the breast or a lump in the armpit.\"\n\n\"BIA-ALCL has been known to occur as soon as one year after the operation and as late as 37 years after the operation. The average time to diagnosis is within 8 years of the operation.\"\n\nhttps://www.tga.gov.au/breast-implant-associated-cancer-bia-alcl-information-consumers\n\n#What is BIA-ALCL? Is BIA-ALCL breast cancer?\n\nBreast Implant Associated Lymphoma (BIA-ALCL) is not breast cancer - it is a type of non-Hodgkin's lymphoma (cancer of the immune system). In most cases, BIA-ALCL is found in the scar tissue and fluid near the implant, but in some cases, it can spread throughout the body. An individual's risk of developing BIA-ALCL is considered to be low; however, this cancer is serious and can lead to death, especially if not treated promptly. In most patients, it is treated successfully with surgery to remove the implant and surrounding scar tissue, and in some patients, also treatment with chemotherapy and radiation therapy.\n\nhttps://www.fda.gov/medical-devices/breast-implants/questions-and-answers-about-breast-implant-associated-anaplastic-large-cell-lymphoma-bia-alcl#:~:text=A2.,can%20spread%20throughout%20the%20body.\n\n#Who can get breast implant associated cancer?\n\n\"All reported cases of breast implant associated cancer in Australia involve patients who have had a textured implant at some point in their life. Based on current evidence, experts do not think breast implant associated cancer is related to either the contents (saline/silicone) or shape (round/teardrop) of the implant.\"\n\n\"Breast implant associated cancer is rare. The recent review by the TGA has found between one in 2,500 and one in 25,000 people with breast implants are diagnosed with the condition in Australia; based on confirmed cases of BIA-ALCL where only one brand of implant had been used. The risk of developing BIA-ALCL increases with increasing texturing of the implant. Implants which have a smooth surfaced have not been associated with BIA-ALCL. Breast implant associated cancer can occur after either reconstruction or augmentation surgery, with 95% of cases occurring between three and 14 years after the insertion of an implant.'\n\nhttps://www.tga.gov.au/breast-implant-associated-cancer-bia-alcl-information-consumers\n\n#How is breast implant associated cancer diagnosed?\n\n\"If you develop swelling of an implanted breast your doctor will send you for an ultrasound scan to see if this is due to a fluid collection. If fluid is present it will be removed and sent to the laboratory for analysis. Most fluid collections are not due to BIA-ALCL, but the laboratory test will be able to tell for sure.\"\n\n\"If confirmed, your specialist may also order an MRI scan or CT scan to assess the extent of local growth or distant spread of the cancer. Other tests such as a PET scan may be also used to assess spread.\"\n\n\"A mammogram will check for breast cancer, but is not useful for detecting BIA-ALCL.\"\n\nhttps://www.tga.gov.au/breast-implant-associated-cancer-bia-alcl-information-consumers",
      "votes": 7
    }
  ],
  "comments": [],
  "raw_markdown_by_id": {
    "2049200": "#Normal Breast Implants. What We Must Know to Avoid Misinterpretations\n\n\n\"Nowadays there are many different types of breast implants and some of them with particular landmarks that could lead to misinterpretations by unexperienced radiologists.The authors selected 10 types of implants from different manufacturers commonly used in plastic surgery.The purpose of this exhibit is: To demonstrate the most common types of breast implants, especially some specific landmarks and main anatomical features that could lead to misinterpretations; To demonstrate in detail the microscopic anatomical characteristics of breast implants shell; To correlate the findings of both in vitro and in vivo through different imaging modalities: mammography, ultrasound and MRI.\"\n\nhttps://archive.rsna.org/2015/MagneticResonanceImaging.pdf\n\n#What is breast implant associated cancer?\n\n\"Breast implant associated cancer, which is also known as breast implant associated anaplastic large cell lymphoma (BIA-ALCL), is a rare cancer of the immune system. It is not breast cancer, which forms from cells in the breast, but instead a cancer that grows in the fluid and scar tissue that forms around a breast implant. Less commonly, BIA-ALCL can take the form of a lump in the breast or a lump in the armpit.\"\n\n\"BIA-ALCL has been known to occur as soon as one year after the operation and as late as 37 years after the operation. The average time to diagnosis is within 8 years of the operation.\"\n\nhttps://www.tga.gov.au/breast-implant-associated-cancer-bia-alcl-information-consumers\n\n#What is BIA-ALCL? Is BIA-ALCL breast cancer?\n\nBreast Implant Associated Lymphoma (BIA-ALCL) is not breast cancer - it is a type of non-Hodgkin's lymphoma (cancer of the immune system). In most cases, BIA-ALCL is found in the scar tissue and fluid near the implant, but in some cases, it can spread throughout the body. An individual's risk of developing BIA-ALCL is considered to be low; however, this cancer is serious and can lead to death, especially if not treated promptly. In most patients, it is treated successfully with surgery to remove the implant and surrounding scar tissue, and in some patients, also treatment with chemotherapy and radiation therapy.\n\nhttps://www.fda.gov/medical-devices/breast-implants/questions-and-answers-about-breast-implant-associated-anaplastic-large-cell-lymphoma-bia-alcl#:~:text=A2.,can%20spread%20throughout%20the%20body.\n\n#Who can get breast implant associated cancer?\n\n\"All reported cases of breast implant associated cancer in Australia involve patients who have had a textured implant at some point in their life. Based on current evidence, experts do not think breast implant associated cancer is related to either the contents (saline/silicone) or shape (round/teardrop) of the implant.\"\n\n\"Breast implant associated cancer is rare. The recent review by the TGA has found between one in 2,500 and one in 25,000 people with breast implants are diagnosed with the condition in Australia; based on confirmed cases of BIA-ALCL where only one brand of implant had been used. The risk of developing BIA-ALCL increases with increasing texturing of the implant. Implants which have a smooth surfaced have not been associated with BIA-ALCL. Breast implant associated cancer can occur after either reconstruction or augmentation surgery, with 95% of cases occurring between three and 14 years after the insertion of an implant.'\n\nhttps://www.tga.gov.au/breast-implant-associated-cancer-bia-alcl-information-consumers\n\n#How is breast implant associated cancer diagnosed?\n\n\"If you develop swelling of an implanted breast your doctor will send you for an ultrasound scan to see if this is due to a fluid collection. If fluid is present it will be removed and sent to the laboratory for analysis. Most fluid collections are not due to BIA-ALCL, but the laboratory test will be able to tell for sure.\"\n\n\"If confirmed, your specialist may also order an MRI scan or CT scan to assess the extent of local growth or distant spread of the cancer. Other tests such as a PET scan may be also used to assess spread.\"\n\n\"A mammogram will check for breast cancer, but is not useful for detecting BIA-ALCL.\"\n\nhttps://www.tga.gov.au/breast-implant-associated-cancer-bia-alcl-information-consumers"
  }
}